MANCINI, ANDREA

MANCINI, ANDREA  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.045 secondi).
Titolo Data di pubblicazione Autore(i) File
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 1-gen-2020 Colapietro, A.; Mancini, A.; Vitale, F.; Martellucci, S.; Angelucci, A.; Llorens, S.; Mattei, V.; Gravina, G. L.; Alonso, G. L.; Festuccia, C.
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 1-gen-2020 Festuccia, Claudio; Colapietro, Alessandro; Mancini, Andrea; D'Alessandro, Annamaria
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 1-gen-2019 Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 1-gen-2019 Marampon, F.; Leoni, F.; Mancini, A.; Pietrantoni, I.; Codenotti, S.; Ferella, L.; Megiorni, F.; Porro, G.; Galbiati, E.; Pozzi, P.; Mascagni, P.; Budillon, A.; Maggio, R.; Tombolini, V.; Fanzani, A.; Gravina, G. L.; Festuccia, C.
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 1-gen-2018 Festuccia, C; Mancini, A; Colapietro, A; Gravina, G L; Vitale, F; Marampon, F; Delle Monache, S; Pompili, S; Cristiano, L; Vetuschi, A; Tombolini, V; Chen, Y; Mehrling, T
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 1-gen-2018 Festuccia, Claudio; Gravina, Giovanni Luca; Giorgio, Carmine; Mancini, Andrea; Pellegrini, Cristina; Colapietro, Alessandro; Monache, Simona Delle; Maturo, Maria Giovanna; Sferra, Roberta; Chiodelli, Paola; Rusnati, Marco; Cantoni, Annamaria; Castelli, Riccardo; Vacondio, Federica; Lodola, Alessio; Tognolini, Massimiliano
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 1-gen-2017 Gravina, GIOVANNI LUCA; Mancini, Andrea; Marampon, Francesco; Colapietro, Alessandro; DELLE MONACHE, Simona; Sferra, Roberta; Vitale, Flora; Richardson, Peter J.; Patient, Lee; Burbidge, Stephen; Festuccia, Claudio
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 1-gen-2017 Vignaroli, G.; Iovenitti, G.; Zamperini, C.; Coniglio, F.; Calandro, P.; Molinari, A.; Fallacara, A. L.; Sartucci, A.; Calgani, A.; Colecchia, D.; Mancini, A.; Festuccia, C.; Dreassi, E.; Valoti, M.; Musumeci, F.; Chiariello, M.; Angelucci, A.; Botta, M.; Schenone, S.
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 1-gen-2016 Gravina, GIOVANNI LUCA; Mancini, Andrea; Scarsella, Luca; Colapietro, Alessandro; Jitariuc, Ana; Vitale, Flora; Marampon, Francesco; Ricevuto, Enrico; Festuccia, Claudio
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 1-gen-2015 Festuccia, Claudio; Gravina, GIOVANNI LUCA; Mancini, Andrea; DELLE MONACHE, Simona; Sanita', Patrizia; Tognolini, M; Castelli, R; Lodola, A.
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 1-gen-2015 Vitti, Maurizio; Mancini, Andrea; DI EMIDIO, Giovanna; DI CARLO, Michela; Artini, PAOLO GIOVANNI; Festuccia, Claudio; Carta, Gaspare; D'Alessandro, Anna Maria; Tatone, Carla
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 1-gen-2015 Gravina, GIOVANNI LUCA; Mancini, Andrea; Muzi, Paola; Ventura, Luca; Biordi, ASSUNTA LEDA; Ricevuto, Enrico; Pompili, Simona; Mattei, Claudia; DI CESARE, Ernesto; Jannini, Emmanuele A.; Festuccia, Claudio
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 1-gen-2015 Vitti, M.; Mancini, A.; Di Emidio, G.; Di Carlo, M.; Artini, Pg.; Festuccia, C.; Carta, G.; D’Alessandro, Am.; Tatone, C.
Possible involvement of SIRT1 and FOXO3a in oxidative stress response and aging of human granulosa cells 1-gen-2012 DI EMIDIO, Giovanna; Vitti, Maurizio; Mancini, Andrea; Baldassarra, T; D'Alessandro, Anna Maria; Polsinelli, F; Tatone, Carla
Possible role or SIRT 1in human ovarian granulosa cells 1-gen-2011 Di Emidio, G; Mancini, A; Falone, Stefano; Lizzi, Ar; Polsinelli, F; Amicarelli, F; Tatone, Carla; D'Alessandro, Anna Maria
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 1-gen-2007 Fusco, A.; Bianchi, A.; Mancini, A.; Milardi, D.; Giampietro, A.; Cimino, V.; Porcelli, T.; Romualdi, D.; Guido, M.; Lanzone, A.; Pontecorvi, A.; De Marinis, L.
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 1-gen-2004 Villa, P.; De Marinis, L.; Mancini, A.; Guido, M.; Selvaggi, L.; Lanzone, A.